NCT00789321 A Study to Evaluate Methodologies for Measuring Swelling of the Leg and Ankle (MK-0000-106)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00787527 SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00787371 Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED) Status COMPLETED Phase PHASE2
NCT00786409 Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women Status COMPLETED Phase NA
NCT00785798 Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas Status TERMINATED Phase PHASE1/PHASE2
NCT00783393 SCH 52365 Phase II Clinical Study: A Study on the Efficacy and Safety of Monotherapy With SCH 52365 in Patients With First Relapsed Anaplastic Astrocytoma (Study P03745) Status COMPLETED Phase PHASE2
NCT00782951 A Comparison of Analgesic Efficacy Between a Single Dose of ORG 28611, Morphine, and Placebo After Dental Impaction Surgery (Study P05800) Status TERMINATED Phase PHASE2
NCT00782418 A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00781846 Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers (8669-010)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00781768 Odansetron and Dexamethasone Alone vs. Odansetron, Dexamethason and Apreptant to Prevent Nausea Status COMPLETED Phase PHASE4
NCT00781469 A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood Status TERMINATED Phase N/A
NCT00781287 Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1 Status TERMINATED Phase PHASE4
NCT00780585 A Follow up Safety Study of Patients Who Participated in Previous Studies of the Drug Org 24448 (Study P05719)(COMPLETED) Status COMPLETED Phase N/A
NCT00780039 A Study to Evaluate the Safety and Efficacy of Caelyx in Combination With Carboplatin in Patients With Ovarian Cancer Recurrent Within Six to Twelve Months After Initial Carboplatin and Paclitaxel Chemotherapy (P03625) Status COMPLETED Phase PHASE2
NCT00779935 Growth Factor Concentration to Predict an Ankylosing Spondylitis Patient's Response to Infliximab (Study P04041)(COMPLETED) Status COMPLETED Phase PHASE4
NCT00779584 A Dose-escalation Study of MK-8776 (SCH 900776) With and Without Gemcitabine in Participants With Solid Tumors or Lymphoma (MK-8776-002/P05248) Status COMPLETED Phase PHASE1